Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Middleton

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Human Genetics|March 1, 1993
Physical mapping identifies DXS265 as a useful genetic marker for carrier detection and prenatal diagnosis of X-linked agammaglobulinemiaR Lovering, A K Sweatman, M A O'Reilly, et al.
American Journal of Medical Genetics|December 1, 1992
Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome: a consequence of twinningB Winchester, E Young, S Geddes, et al.
The Journal of Arthroplasty|December 26, 2021
Do In-Hospital Rothman Index Scores Predict Postdischarge Adverse Events and Discharge Location After Total Knee Arthroplasty?Andrew D Kleven, Austin H Middleton, Ziynet Nesibe Kesimoglu, et al.
Pediatric Blood & Cancer|February 18, 2004
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) studyR G Grundy, C Hutton, H Middleton, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitroD A Norris, M H Middleton, K Whang, et al.
Radiation Oncology (London, England)|August 14, 2016
Investigation of a real-time EPID-based patient dose monitoring safety system using site-specific control limitsTodsaporn Fuangrod, Peter B Greer, Henry C Woodruff, et al.
Journal of Immunological Methods|November 5, 1993
Carrier determination for X-linked agammaglobulinemia using X inactivation analysis of purified B cellsL A Alterman, M de Alwis, S Genet, et al.
Genomics|May 1, 1993
Norrie disease gene: characterization of deletions and possible functionZ Y Chen, E M Battinelli, R W Hendriks, et al.
Magnetic Resonance in Medicine|February 1, 1995
MR imaging with hyperpolarized 3He gasH Middleton, R D Black, B Saam, et al.
British Journal of Cancer|August 17, 2000
The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour studyC Mitchell, P M Jones, A Kelsey, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Human Genetics|March 1, 1993
Physical mapping identifies DXS265 as a useful genetic marker for carrier detection and prenatal diagnosis of X-linked agammaglobulinemiaR Lovering, A K Sweatman, M A O'Reilly, et al.
American Journal of Medical Genetics|December 1, 1992
Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome: a consequence of twinningB Winchester, E Young, S Geddes, et al.
The Journal of Arthroplasty|December 26, 2021
Do In-Hospital Rothman Index Scores Predict Postdischarge Adverse Events and Discharge Location After Total Knee Arthroplasty?Andrew D Kleven, Austin H Middleton, Ziynet Nesibe Kesimoglu, et al.
Pediatric Blood & Cancer|February 18, 2004
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) studyR G Grundy, C Hutton, H Middleton, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitroD A Norris, M H Middleton, K Whang, et al.
Radiation Oncology (London, England)|August 14, 2016
Investigation of a real-time EPID-based patient dose monitoring safety system using site-specific control limitsTodsaporn Fuangrod, Peter B Greer, Henry C Woodruff, et al.
Journal of Immunological Methods|November 5, 1993
Carrier determination for X-linked agammaglobulinemia using X inactivation analysis of purified B cellsL A Alterman, M de Alwis, S Genet, et al.
Genomics|May 1, 1993
Norrie disease gene: characterization of deletions and possible functionZ Y Chen, E M Battinelli, R W Hendriks, et al.
Magnetic Resonance in Medicine|February 1, 1995
MR imaging with hyperpolarized 3He gasH Middleton, R D Black, B Saam, et al.
British Journal of Cancer|August 17, 2000
The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour studyC Mitchell, P M Jones, A Kelsey, et al.
Pageof 12